Trial Profile
A Randomised Study of Taurolock for the Locking of Tunneled Central Venous Catheters in Children With Malignant Diseases.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2015
Price :
$35
*
At a glance
- Drugs Taurolidine (Primary) ; Heparin
- Indications Bacteraemia; Catheter infections
- Focus Therapeutic Use
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Sep 2008 New trial record.